Nurix Therapeutics, Inc (NRIX) insider trading
Every open-market stock purchase and sale by Nurix Therapeutics, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- Christine Ring (C-suite exec) and 3 others sold $1.8M in the last 90 days.
- No open-market insider buys on record.
Last 12 months: insiders bought $0 (0 buys) and sold $5.2M (35 sales). Last close $26.02 on Oct 21, 2026.
Recent NRIX insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| Oct 15, 2026 | Gwenn Hansen (C-suite exec) | Sold | $36.3K |
| Oct 15, 2026 | Gwenn Hansen (C-suite exec) | Bought (not open market) | $2.7K |
| Oct 15, 2026 | Gwenn Hansen (C-suite exec) | Bought (not open market) | — |
| Oct 14, 2026 | Julia P Gregory (Director) | Sold | $529K |
| Oct 14, 2026 | Julia P Gregory (Director) | Bought (not open market) | $42K |
| Oct 14, 2026 | Julia P Gregory (Director) | Bought (not open market) | — |
| Oct 2, 2026 | Christine Ring (C-suite exec) | Sold | $134K |
| Oct 2, 2026 | Christine Ring (C-suite exec) | Bought (not open market) | — |
| Sep 2, 2026 | Christine Ring (C-suite exec) | Sold | $138K |
| Sep 2, 2026 | Christine Ring (C-suite exec) | Sold | $10.7K |
| Sep 2, 2026 | Christine Ring (C-suite exec) | Bought (not open market) | — |
| Sep 1, 2026 | Gwenn Hansen (C-suite exec) | Sold | $37K |
| Sep 1, 2026 | Gwenn Hansen (C-suite exec) | Bought (not open market) | — |
| Aug 5, 2026 | Gwenn Hansen (C-suite exec) | Sold | $109K |
| Aug 5, 2026 | Gwenn Hansen (C-suite exec) | Bought (not open market) | — |
| Aug 4, 2026 | Hans van Houte (CFO) | Sold | $73.1K |
| Aug 4, 2026 | Gwenn Hansen (C-suite exec) | Sold | $64.3K |
| Aug 4, 2026 | Hans van Houte (CFO) | Sold | $42.9K |
| Aug 4, 2026 | Gwenn Hansen (C-suite exec) | Sold | $35.8K |
| Aug 3, 2026 | Christine Ring (C-suite exec) | Sold | $382K |
| Aug 3, 2026 | Christine Ring (C-suite exec) | Bought (not open market) | — |
| Jul 30, 2026 | Christine Ring (C-suite exec) | Sold | $90K |
| Jul 30, 2026 | Gwenn Hansen (C-suite exec) | Sold | $90K |
| Jul 30, 2026 | Hans van Houte (CFO) | Sold | $66.5K |
| Jul 30, 2026 | Hans van Houte (CFO) | Bought (not open market) | — |
Who's trading NRIX
- Gwenn Hansen, C-suite exec: sold $667K (11 sales), last Oct 15, 2026
- Julia P Gregory, Director: sold $529K (1 sale), last Oct 14, 2026
- Christine Ring, C-suite exec: sold $3.4M (21 sales), last Oct 2, 2026
- Hans van Houte, CFO: sold $635K (10 sales), last Aug 4, 2026
- Judith A Reinsdorf, Director: other filings, last May 15, 2026
- David L. Lacey, Director: other filings, last May 15, 2026
- Roger D Dansey, Director: other filings, last May 15, 2026
- Anil Kapur, Director: other filings, last May 15, 2026
- Roy D. Baynes, Director: other filings, last May 15, 2026
- Edward C Saltzman, Director: other filings, last May 15, 2026
- Paul M Silva, Director: other filings, last May 15, 2026
- Arthur T Sands, CEO: other filings, last Feb 10, 2026
Get free alerts when an insider at Nurix Therapeutics, Inc files a new trade →